1. MARKETS
  2. SECTOR : HEALTHCARE & MEDICAL EQUIPMENT SUPPLIERS
  3. INDUSTRY : MEDICAL SPECIALTIES
  4. MYRIAD GENETICS, INC.
Myriad Genetics, Inc. XNAS: MYGN
4.95 -0.17 (-3.32%)
318.2K
XNAS Volume

XNAS 11 Mar, 2026 10:21 AM (EDT)

Watchlist

Portfolio

Alert

Board Meeting
The latest board meeting for Myriad Genetics Inc took place on 10 Mar 2026, for the purpose of Leerink Partners Global Healthcare Conference See details

Myriad Genetics Inc - MYGN - stock price prediction, stock price target, analyst ratings from 12 analysts

Myriad Genetics Inc has a share price target of US$ 8, revenue growth forecast of 5.0%, and profit growth estimate of 81.4% for FY26, based on top 12 analyst calls.